Case 3: CB is a 38-year-old man, employed as a carpenter, who presents with a 2-month history of pain in multiple joints that has caused difficulty in using tools and carrying lumber at work. CB has a family history of RA, and his mother was HLADR4+.
Case 3: CB is a 38-year-old man, employed as a carpenter, who presents with a 2-month history of pain in multiple joints that has caused difficulty in using tools and carrying lumber at work. CB has a family history of RA, and his mother was HLADR4+.
Case Study
Faculty
John R. P. Tesser, MD
Rheumatologist
Arizona Arthritis & Rheumatology Research, PLLC
Clinical Lecturer
University of Arizona College of Medicine
Paradise Valley, Arizona
Intended Learners
Rheumatologists and related healthcare professionals who treat rheumatic disease patients
Learning Objectives
After completing this activity, participants should be able to:
- Integrate updated ACR/EULAR classification and remission criteria to increase a patient's chances of remission or low disease activity through early, aggressive treatment
- Utilize patient self-report and clinical measurement tools in everyday clinical practice to optimize patient care strategies
- Outline genetic associations, laboratory markers, and clinical manifestations which should be considered when initiating early, aggressive RA therapy
- Interpret current and new safety and efficacy data, including those presented at ACR and EULAR, on combination therapy, triple DMARD therapy, and biologic switching
- Describe new treatment targets and novel approaches for RA patients who have failed on conventional therapies, including mechanisms of action and safety considerations
Activity Overview
This on-demand case vignette consists of a patient case study with integrated polling questions.
To be eligible for documentation of credit, participants must review the case study, answer all polling questions, complete the 5-question post-test with a score of 80% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Release date: June 30, 2011
Expiration date: June 30, 2012
Estimated time to complete: .5 hour
There is no fee associated with this activity.
For questions regarding this activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Independent Clinical Reviewer: Rodolfo Curiel, MD, Assistant Professor of Medicine, The George Washington University Medical Center, Washington, DC
Planning Committee
The planning committee comprises Rodolfo Curiel, MD, and John R. P. Tesser, MD; Kay Weigand, University of Cincinnati; Stephen Chavez, Emilie McCardell, Randy Robbin, Alicia Rybovic, and John Savage, North American Center for Continuing Medical Education, LLC (NACCME).
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME and the University of Cincinnati, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Curiel has disclosed no relevant financial relationships with any commercial interest.
Dr. Tesser: Grant/Research Support—Abbott Laboratories, AstraZeneca, Biogen Idec Inc, Centocor Ortho Biotech Inc, Eli Lilly and Co., F. Hoffman La Roche Ltd, Genentech Inc, Incyte Corporation, Merck & Co, Inc., Pfizer Inc, UCB Inc.; Consultant—Bristol-Myers Squibb Company, Genentech Inc, Pfizer Inc, UCB Inc.; Scientific Advisor—Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, Genentech Inc, Pfizer Inc, UCB Inc.; Promotional Speakers’ Bureau—Abbott Laboratories, Amgen Inc, Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, GlaxoSmithKline, Pfizer Inc.
Ms. Weigand, Mr. Chavez, Mr. Robbin, Ms. McCardell, and Mr. Savage have disclosed no relevant financial relationships with any commercial interest.
Ms. Rybovic: Stock Shareholder—Novo Nordisk, Amgen Inc.
NACCME and the University of Cincinnati requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations. The faculty has disclosed that investigational agents will be discussed in this activity.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
CORE™ is supported by educational grants from Abbott Laboratories Inc., Bristol-Myers Squibb Co, Centocor Ortho Biotech Inc., Genentech Inc., Pfizer, Inc., and UCB Inc.
